Wavemind, Author at BioAlps https://bioalps.org/author/wmdevg15/ Your entry point to a wealth of contacts, know-how and knowledge, for both personal and institutional support: BioAlps, the life science cluster of Western Switzerland. Mon, 19 Jan 2026 14:19:18 +0000 en-US hourly 1 https://wordpress.org/?v=6.9 https://bioalps.org/app/uploads/2022/11/cropped-favicon-32x32.png Wavemind, Author at BioAlps https://bioalps.org/author/wmdevg15/ 32 32 Hospitalar https://bioalps.org/hospitalar/ Wed, 16 Jan 2019 07:58:02 +0000 https://bioalps.org/?p=2603 HospitalarHospitalar will take place from 19 to 22 May 2026 in São Paulo, Brazil. It is the main International Fair of Products, Equipment, Services and Technology for Hospitals, Laboratories, Pharmacies, Health Clinics and Medical Offices.   Hospitalar is the most complete and specialized trade fair for the healthcare sector in Brazil and Latin America. It offers…

The post Hospitalar appeared first on BioAlps.

]]>

Hospitalar will take place from 19 to 22 May 2026 in São Paulo, Brazil. It is the main International Fair of Products, Equipment, Services and Technology for Hospitals, Laboratories, Pharmacies, Health Clinics and Medical Offices.

 

Hospitalar is the most complete and specialized trade fair for the healthcare sector in Brazil and Latin America. It offers a broad platform for all national and international manufacturers and distributors of medical technology, healthcare equipment and consumer goods, as well as hospital management, training, education, among others.

The target audience is healthcare professionals (physicians, hospital management, suppliers, nursing, rehabilitation, diagnostic centers, laboratories) from Brazil and Latin America. The exhibition aims to provide information on the latest products, equipment and technologies.

In its last edition, the event received more than 85,000 professional visits from 55 countries and had around 1,200 exhibiting brands from 30 different countries, consolidating itself as the largest and most important event in the sector in Latin America.

SWISSCAM (the Swiss-Brazilian Chamber of Commerce) has organized the collective stand at this fair since 2004, consolidating its expertise in the area. The Swiss Pavilion is a great opportunity for Swiss and Liechtenstein companies, as it ensures that the company is well located within the fair and present under the Swiss umbrella, always a symbol of innovation and expertise.

 


🗓 19 – 22 May 2026
📍Saõ Paulo, Brazil
➡ Information

The post Hospitalar appeared first on BioAlps.

]]> Bristol-Myers Squibb to Acquire Celgene for About Billion https://bioalps.org/bristol-myers-squibb-to-acquire-celgene-for-about-billion/ Thu, 03 Jan 2019 10:42:43 +0000 https://bioalps.org/?p=2438 “The combined company will have nine products with more than billion in annual sales” Read full article in English from the Wall Street Journal

The post Bristol-Myers Squibb to Acquire Celgene for About Billion appeared first on BioAlps.

]]>
“The combined company will have nine products with more than billion in annual sales”

The post Bristol-Myers Squibb to Acquire Celgene for About Billion appeared first on BioAlps.

]]> HES-SO launch two personalized medicine national projects https://bioalps.org/hes-so-launch-two-personalized-medicine-national-projects/ Tue, 18 Dec 2018 10:48:03 +0000 https://bioalps.org/?p=2443 The projects link personalized medicine and AI to offer the most efficient support at different stages of illness. Read full article about the projects in French

The post HES-SO launch two personalized medicine national projects appeared first on BioAlps.

]]>
The projects link personalized medicine and AI to offer the most efficient support at different stages of illness.

The post HES-SO launch two personalized medicine national projects appeared first on BioAlps.

]]> Meet Christophe Ramstein, CEO of Myotest https://bioalps.org/meet-christophe-ramstein-ceo-of-myotest/ Tue, 18 Dec 2018 10:46:56 +0000 https://bioalps.org/?p=2440 The Valais based startup provides personalized smart coaching software and services for runners to achieve their performance goals confidently, improve their efficiency, and select the right shoes, based on their own unique physiology. View the full interview in French

The post Meet Christophe Ramstein, CEO of Myotest appeared first on BioAlps.

]]>
The Valais based startup provides personalized smart coaching software and services for runners to achieve their performance goals confidently, improve their efficiency, and select the right shoes, based on their own unique physiology.

The post Meet Christophe Ramstein, CEO of Myotest appeared first on BioAlps.

]]> Using water molecules to unlock neurons’ secrets https://bioalps.org/using-water-molecules-to-unlock-neurons-secrets/ Wed, 12 Dec 2018 10:49:51 +0000 https://bioalps.org/?p=2447 EPFL News : “EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the behavior of surrounding water molecules. This simple and non-invasive method, which could eliminate the need for electrodes and fluorophores, can be used to monitor the activity within a single neuron or potentially on an entire region…

The post Using water molecules to unlock neurons’ secrets appeared first on BioAlps.

]]>
EPFL News : “EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the behavior of surrounding water molecules. This simple and non-invasive method, which could eliminate the need for electrodes and fluorophores, can be used to monitor the activity within a single neuron or potentially on an entire region of the brain.”

The post Using water molecules to unlock neurons’ secrets appeared first on BioAlps.

]]> Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux https://bioalps.org/proteine-anti-interference-pour-la-securite-des-transfusions-sanguines-chez-les-patients-cancereux/ Mon, 10 Dec 2018 10:54:13 +0000 https://bioalps.org/?p=2453 GrifolsMedion Grifols Diagnostics finaliste du Prix Entreprise 2018/2019 du Canton de Fribourg. “Des nouveaux médicaments contre le cancer affectent les résultats des tests sanguins de diagnostic, de sorte que ces derniers ne sont plus fiables. Medion Grifols Diagnostics a développé une protéine qui élimine ce trouble. Grâce à la protéine anti-interférence de Grifols, Medion a…

The post Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux appeared first on BioAlps.

]]>

Medion Grifols Diagnostics finaliste du Prix Entreprise 2018/2019 du Canton de Fribourg.

“Des nouveaux médicaments contre le cancer affectent les résultats des tests sanguins de diagnostic, de sorte que ces derniers ne sont plus fiables. Medion Grifols Diagnostics a développé une protéine qui élimine ce trouble. Grâce à la protéine anti-interférence de Grifols, Medion a résolu un problème précédemment adressé de manière non satisfaisante dans la médecine transfusionnelle et a rendu possible des transfusions sanguines sûres chez les patients atteints de cancers.”

Voir la vidéo (FR/DE/ANG, 2:03 min)

The post Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux appeared first on BioAlps.

]]> Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM. https://bioalps.org/industrialise-avec-le-soutien-technologique-du-csem-sun-bioscience-lance-sa-plateforme-gri3dtm/ Mon, 10 Dec 2018 10:50:49 +0000 https://bioalps.org/?p=2451 Cet outil représente une première et propulse les organoïdes dans une nouvelle La culture in vitro standardisée, rapide et fiable de cellules souches du patient pour produire des mini-organes est en effet une des clés de la médecine personnalisée Press Release

The post Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM. appeared first on BioAlps.

]]>

Cet outil représente une première et propulse les organoïdes dans une nouvelle La culture in vitro standardisée, rapide et fiable de cellules souches du patient pour produire des mini-organes est en effet une des clés de la médecine personnalisée

The post Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM. appeared first on BioAlps.

]]> Médecins, mais entrepreneurs dans l’âme https://bioalps.org/medecins-mais-entrepreneurs-dans-lame/ Sun, 02 Dec 2018 10:55:19 +0000 https://bioalps.org/?p=2455 “Deux médecins, l’un au CHUV et l’autre aux HUG, développent des applications qui pourraient s’avérer révolutionnaires. Celles-ci transforment les smartphones en stéthoscope et en tensiomètre. La valorisation des inventions nées dans les hôpitaux reste toutefois une question délicate.” Lire l’article complet dans Le Temps en français

The post Médecins, mais entrepreneurs dans l’âme appeared first on BioAlps.

]]>
“Deux médecins, l’un au CHUV et l’autre aux HUG, développent des applications qui pourraient s’avérer révolutionnaires. Celles-ci transforment les smartphones en stéthoscope et en tensiomètre. La valorisation des inventions nées dans les hôpitaux reste toutefois une question délicate.”

The post Médecins, mais entrepreneurs dans l’âme appeared first on BioAlps.

]]> BioAlps Prize 2018 https://bioalps.org/bioalps-prize-2018/ Thu, 29 Nov 2018 10:56:17 +0000 https://bioalps.org/?p=2457 We are very proud to announce the winners of the BioAlps Academy and Industry Prizes 2018. The BioAlps Award aims to honor a personality and an enterprise from the life sciences sector without whom western Switzerland would not have acquired its international reputation in this field. This year’s BioAlps Academy Prize goes to Prof Dr.…

The post BioAlps Prize 2018 appeared first on BioAlps.

]]>
We are very proud to announce the winners of the BioAlps Academy and Industry Prizes 2018.

The BioAlps Award aims to honor a personality and an enterprise from the life sciences sector without whom western Switzerland would not have acquired its international reputation in this field.

BioAlps Award 2018

This year’s BioAlps Academy Prize goes to Prof Dr. Benoît Dubuis from the Campus Biotech and Wyss Center. The BioAlps Industry Prize has been awarded to Medtronic Tolochenaz.

The post BioAlps Prize 2018 appeared first on BioAlps.

]]> ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie https://bioalps.org/adc-therapeutics-pemiers-patients-traites-en-phase-i-ii-sur-adc-602-pour-le-traitement-de-leucemie/ Wed, 28 Nov 2018 11:00:43 +0000 https://bioalps.org/?p=2468 ADC Therapeutics annonce les premiers patients traités dans le cadre de l’essai clinique de Phase I/II sur ADCT-602 dans le traitement de la leucémie aigüe lymphoblastique à lymphocytes B en rechute ou réfractaire Plus d’infos

The post ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie appeared first on BioAlps.

]]>
ADC Therapeutics annonce les premiers patients traités dans le cadre de l’essai clinique de Phase I/II sur ADCT-602 dans le traitement de la leucémie aigüe lymphoblastique à lymphocytes B en rechute ou réfractaire

The post ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie appeared first on BioAlps.

]]>